Publication:
Comparison of single-dose and repeated levosimendan infusion in patients with acute exacerbation of advanced heart failure

Thumbnail Image

Organizational Units

Program

Authors

Tasal, Abdurrahman
DEMİR, MESUT
KANADAŞI, MEHMET
BACAKSIZ, AHMET
Vatankulu, Mehmet Akif
Sahin, Durmus Yildiray
Eker, Rabia Akilli
BOZKURT, ABDİ
Acarturk, Esmeray

Advisor

Language

Publisher

Journal Title

Journal ISSN

Volume Title

Abstract

Background: Levosimendan (LS) is a novel inodilator that improves cardiac performance, central hemodynamics, and symptoms of patients with decompensated chronic heart failure. The aim of this study was to compare the effects of single and repeated LS infusion on left ventricular performance, biomarkers, and neurohormonal activation in patients with acute heart failure.

Description

Source:

Keywords:

Keywords

Citation

Tasal A., DEMİR M., KANADAŞI M., BACAKSIZ A., Vatankulu M. A. , Sahin D. Y. , Eker R. A. , BOZKURT A., Acarturk E., -Comparison of single-dose and repeated levosimendan infusion in patients with acute exacerbation of advanced heart failure-, MEDICAL SCIENCE MONITOR, cilt.20, 2014

Endorsement

Review

Supplemented By

Referenced By

1

Views

2

Downloads

View PlumX Details


Sustainable Development Goals